IL326764A - תצמידי נוגדן-תרופה - Google Patents

תצמידי נוגדן-תרופה

Info

Publication number
IL326764A
IL326764A IL326764A IL32676426A IL326764A IL 326764 A IL326764 A IL 326764A IL 326764 A IL326764 A IL 326764A IL 32676426 A IL32676426 A IL 32676426A IL 326764 A IL326764 A IL 326764A
Authority
IL
Israel
Prior art keywords
antibody
drug conjugates
conjugates
drug
Prior art date
Application number
IL326764A
Other languages
English (en)
Original Assignee
Nextpoint Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextpoint Therapeutics Inc filed Critical Nextpoint Therapeutics Inc
Publication of IL326764A publication Critical patent/IL326764A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/68037—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a camptothecin [CPT] or derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL326764A 2023-09-08 2024-09-06 תצמידי נוגדן-תרופה IL326764A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202363581306P 2023-09-08 2023-09-08
US202363591078P 2023-10-17 2023-10-17
US202463550023P 2024-02-05 2024-02-05
PCT/US2024/045733 WO2025054560A2 (en) 2023-09-08 2024-09-06 Antibody-drug conjugates

Publications (1)

Publication Number Publication Date
IL326764A true IL326764A (he) 2026-04-01

Family

ID=94924415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326764A IL326764A (he) 2023-09-08 2024-09-06 תצמידי נוגדן-תרופה

Country Status (3)

Country Link
AU (1) AU2024335515A1 (he)
IL (1) IL326764A (he)
WO (1) WO2025054560A2 (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025149667A1 (en) * 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
WO2026016639A1 (zh) * 2024-07-19 2026-01-22 昆山新蕴达生物科技有限公司 一种靶向adam-9的抗体-药物偶联物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017114763A (ja) * 2014-03-26 2017-06-29 第一三共株式会社 抗ｃｄ９８抗体−薬物コンジュゲート
CN112125915A (zh) * 2019-09-18 2020-12-25 四川百利药业有限责任公司 一种喜树碱衍生物及其偶联物
MX2022008474A (es) * 2020-01-22 2022-08-02 Jiangsu Hengrui Medicine Co Conjugado de anticuerpo anti-trop-2-analogo de exatecan y uso medico del mismo.
WO2022165258A1 (en) * 2021-01-28 2022-08-04 Nextpoint Therapeutics, Inc. Hhla2 binding agents with novel activity

Also Published As

Publication number Publication date
WO2025054560A2 (en) 2025-03-13
AU2024335515A1 (en) 2026-03-05
WO2025054560A3 (en) 2025-04-24

Similar Documents

Publication Publication Date Title
EP4183421A4 (en) Antibody drug conjugate
EP4117729A4 (en) ANTIBODY DRUG CONJUGATE
EP4126067A4 (en) NEODEGRADER CONJUGATES
CA3254933A1 (en) Camptothecin conjugates
IL284274A (he) קוניוגטים של נוגדן ותרופה לשיפור חלון תרפויטי
PL3946464T3 (pl) Związki i ich koniugaty
IL299362A (he) תצמידי נוגדן-תרופה שכוללים נוגדנים נגדh3 -b7
DK4217398T3 (da) Anti-c-met-antistof-lægemiddelkonjugater
IL312845A (he) נגזרות אקסטקן, מקשר-מטענים, ומצומדים שלהן
IL326764A (he) תצמידי נוגדן-תרופה
EP4178559A4 (en) Novel ror1 antibody immunoconjugates
EP4240425A4 (en) Ocular antibody-drug conjugates
EP4308121A4 (en) THERAPEUTIC CONJUGATES
IL292766A (he) תצמידי נוגדן-תרופה ממוקדי קלאודין 18.2
IL291486A (he) מצומדים טיפוליים
IL300176A (he) נוגדנים אנטי- cd228ותצמידי נוגדן-תרופה
IL318188A (he) מצומדי נוגדן-תרופה
IL308811A (he) Neodegrader מצמידים
EP4333898A4 (en) PEPTIDE-LIPID CONJUGATES
GB2594753B (en) Antibody-drug conjugates
IL316653A (he) מצמידים של תרופות נוגדות גוף
EP4112065A4 (en) ANTI-TUMOOR COMPOSITION
EP4171609A4 (en) CYTOKINE CONJUGATES
EP3999592A4 (en) Theranostic conjugates
EP3986939A4 (en) TWO-DRUG ANTIBODY-DRUG CONJUGATE